REGIONAL HEALTH PROPERTIES, INC (RHEP)
Data as of , from SEC Form 4 filings.
See up to 3 months of RHEP. The 7-day demo opens the 1M and 3M ranges and puts RHEP on your watchlist.
Start 7-day demoLatest RHEP insider trades
Bradley Louis Radoff - 10% OwnerOpen-market purchase$8K- Bradley Louis Radoff - 10% OwnerOpen-market purchase$5K
About REGIONAL HEALTH PROPERTIES, INC (RHEP)
RHEP Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 9 | 16,020 | $23K |
| Open-market sale | 2 | 5,100 | $6K |
RHEP insider transactions (Form 4)
6120 Form 4 filings on record, the earliest from Jun 20, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Bradley Louis Radoff - 10% Owner | Open-market purchase | Common Stock | 6,300 | $1.29 | $8K | |
| Bradley Louis Radoff - 10% Owner | Open-market purchase | Common Stock | 3,511 | $1.30 | $5K | |
| Bradley Louis Radoff - 10% Owner | Open-market purchase | Common Stock | 2,000 | $1.43 | $3K | |
| Bradley Louis Radoff - 10% Owner | Open-market purchase | Common Stock | 100 | $1.21 | $121 | |
| Bradley Louis Radoff - 10% Owner | Open-market purchase | Common Stock | 500 | $1.40 | $700 | |
| Bradley Louis Radoff - 10% Owner | Open-market purchase | Common Stock | 1,000 | $1.40 | $1K | |
| Bradley Louis Radoff - 10% Owner | Open-market purchase | Common Stock | 1,009 | $1.42 | $1K | |
| Bradley Louis Radoff - 10% Owner | Open-market sale | Common Stock | 5,000 | $1.15 | $6K | |
| Bradley Louis Radoff - 10% Owner | Open-market sale | Common Stock | 100 | $1.06 | $106 | |
| Bradley Louis Radoff - 10% Owner | Open-market purchase | Series D Preferred Stock | 600 | $2.13 | $1K | |
| Bradley Louis Radoff - 10% Owner | Open-market purchase | Series D Preferred Stock | 1,000 | $2.20 | $2K | |
| Brent Morrison - Officer | Open-market purchase | Common Stock | 5,000 | $1.15 | $6K | |
| Brent Morrison - Officer | Open-market purchase | Series D 8% Cumulative Conv. Redeemable Preferred Shares | 5,000 | $2.02 | $10K | |
| Brent Morrison - Officer | Open-market purchase | Common Stock | 10,000 | $1.18 footnote F1 | $12K | |
| ||||||
| Brent Morrison - Officer | Open-market purchase | Common Stock | 5,000 | $1.27 footnote F1 | $6K | |
| Brent Morrison - Officer | Open-market purchase | Series D 8% Cumulative Conver Redeemable Preferred Shares | 12,000 | $2.01 footnote F2 | $24K | |
| ||||||
| Marlie Davis - Officer | Grant or award | Common Stock | 35,000 footnote F1,F2 | $0.00 | - | |
| Marlie Davis - Officer | Grant or award | Employee Stock Option(right to buy) | 35,000 | $0.00 | - | |
| ||||||
| Steven L. Martin - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 3,000 | $0.00 | - | |
| Steven J. Baileys - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 3,000 | $0.00 | - | |
| Kenneth Wayne Taylor - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 3,000 | $0.00 | - | |
| Gene E. Burleson - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 3,000 | $0.00 | - | |
| F. Scott Kellman - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 3,000 | $0.00 | - | |
| C. Christian Winkle - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 3,000 | $0.00 | - | |
| Brent Morrison - Officer | Grant or award | Common Stock | 100,000 footnote F1,F2 | $0.00 | - | |
| Brent Morrison - Officer | Grant or award | Employee Stock Option | 100,000 | $0.00 | - | |
| ||||||
| Brent Morrison - Officer | Open-market purchase | Common Stock | 4,099 | $1.45 | $6K | |
| Brent Morrison - Officer | Open-market purchase | Common Stock | 1,950 | $1.45 | $3K | |
| Brent Morrison - Officer | Open-market purchase | Common Stock | 5,403 | $1.41 | $8K | |
| Gene E. Burleson - Director | Open-market purchase | Common Stock | 5,000 | $1.99 | $10K | |
| Paul Jason O'Sullivan - Officer | Open-market purchase | Common Stock | 10,600 | $1.85 | $20K | |
| Paul Jason O'Sullivan - Officer | Open-market purchase | Common Stock | 5,600 | $1.92 | $11K | |
| Paul Jason O'Sullivan - Officer | Open-market purchase | Common Stock | 3,800 | $1.80 | $7K | |
| Gene E. Burleson - Director | Grant or award | Common Stock | 3,253 | - | - | |
| Gene E. Burleson - Director | Grant or award | Common Stock | 22 | - | - | |
| Gene E. Burleson - Director | Grant or award | Common Stock | 13,606 | - | - | |
| Gene E. Burleson - Director | Grant or award | Series D 8% Cumulative Conver. Redeemable Preferred Shares | 2,871 | - | - | |
| Gene E. Burleson - Director | Grant or award | Series D 8% Cumulative Conver. Redeemable Preferred Shares | 20 | - | - | |
| Gene E. Burleson - Director | Grant or award | Series D 8% Cumulative Conver. Redeemable Preferred Shares | 12,009 | - | - | |
| Robert M. Thornton Jr. - Officer | Grant or award | Common Stock | 100,000 | $0.00 | - | |
| Robert M. Thornton Jr. - Officer | Grant or award | Common Stock | 125,663 | - | - | |
| Robert M. Thornton Jr. - Officer | Grant or award | Common Stock | 1,133 | - | - | |
| Robert M. Thornton Jr. - Officer | Grant or award | Series D 8% Cumulative Conver Redeemable Preferred Shares | 110,912 | - | - | |
| Robert M. Thornton Jr. - Officer | Grant or award | Series D 8% Cumulative Conver Redeemable Preferred Shares | 1,000 | - | - | |
| Mark J. Stockslager - Officer | Grant or award | Common Stock | 24,484 | - | - | |
| Mark J. Stockslager - Officer | Grant or award | Series D 8% Cumulative Conver Redeemable Preferred Shares | 21,610 | - | - | |
| Steven J. Baileys - Director | Grant or award | Common Stock | 124,911 | - | - | |
| Steven J. Baileys - Director | Grant or award | Common Stock | 11,330 | - | - | |
| Steven J. Baileys - Director | Grant or award | Common Stock | 11,330 | - | - | |
| Steven J. Baileys - Director | Grant or award | Common Stock | 40,788 | - | - | |
| Steven J. Baileys - Director | Grant or award | Common Stock | 362 | - | - | |
| Steven J. Baileys - Director | Grant or award | Series D 8% Cumulative Conver Redeemable Preferred Shares | 110,248 | - | - | |
| Steven J. Baileys - Director | Grant or award | Series D 8% Cumulative Conver Redeemable Preferred Shares | 10,000 | - | - | |
| Steven J. Baileys - Director | Grant or award | Series D 8% Cumulative Conver Redeemable Preferred Shares | 10,000 | - | - | |
| Steven J. Baileys - Director | Grant or award | Series D 8% Cumulative Conver Redeemable Preferred Shares | 36,000 | - | - | |
| Steven J. Baileys - Director | Grant or award | Series D 8% Cumulative Conver Redeemable Preferred Shares | 320 | - | - | |
| Brent Morrison - Officer | Option exercise | Common Stock | 24,000 | $3.32 | $80K | |
| Brent Morrison - Officer | Option exercise | Common Stock | 24,000 | $2.03 | $49K | |
| Brent Morrison - Officer | Grant or award | Common Stock | 65,000 | $0.00 | - | |
| Brent Morrison - Officer | Option exercise | Employee Stock Option (right to buy) | 24,000 | $0.00 | - | |
| Brent Morrison - Officer | Option exercise | Employee Stock Option (right to buy) | 24,000 | $0.00 | - | |
Item 5.02
Item 5.02
Item 7.01, 9.01
Item 1.01, 9.01
RHEP insider trading FAQ
What is the latest insider trade for RHEP?
REGIONAL HEALTH PROPERTIES, INC (RHEP) had 1 insider filing in the last 90 days, with the most recent on 2026-08-04. The full record for RHEP runs to 20 Form 4 filings, the earliest from 2025-06-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RHEP stock?
9 insider purchases of RHEP were filed in the last 90 days, totaling $23K.
How many insiders are selling RHEP stock?
2 insider sales of RHEP were filed in the last 90 days, totaling $6K.
Where can I see RHEP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RHEP Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Real Estate companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Bradley Louis Radoff view on EDGAR
- - Brent Morrison view on EDGAR
- - Brent Morrison view on EDGAR
- - Marlie Davis view on EDGAR
- - Steven L. Martin view on EDGAR
- - Steven J. Baileys view on EDGAR
- - Kenneth Wayne Taylor view on EDGAR
- - Gene E. Burleson view on EDGAR
- - F. Scott Kellman view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Real Estate
- Where RHEP's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RHEP with a 7-day demo
- RHEP on your watchlist
- Every RHEP Form 4 filing on record
- Up to 3 months of RHEP price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
